Accuracy of melanoma detection up in specialized clinics

June 21, 2012
Accuracy of melanoma detection up in specialized clinics
From 1998 to 2007, the accuracy of melanoma detection improved in specialized but not non-specialized clinical settings, according to research published in the July issue of the Journal of the American Academy of Dermatology.

(HealthDay) -- From 1998 to 2007, the accuracy of melanoma detection improved in specialized but not non-specialized clinical settings, according to research published in the July issue of the Journal of the American Academy of Dermatology.

Giuseppe Argenziano, M.D., of Arcispedale Santa Maria Nuova in Reggio Emilia, Italy, and colleagues conducted a 10-year, multicenter study of 300,215 cases of excised between 1998 and 2007 to assess the accuracy of melanoma detection at participating clinics. The number needed to excise (NNE) was measured by dividing the number of excised lesions by the number of melanomas, and changes in NNE were assessed over time and between clinical settings.

Overall, a total of 17,172 melanomas and 283,043 melanocytic nevi were identified. The researchers found that in specialized clinical settings the NNE was 8.7, whereas in non-specialized the NNE was 29.4. Over time, the NNE in specialty clinics improved from 12.8 to 6.8 but failed to improve in non-specialty clinics. For patients younger than 40 years and for lesions located on the trunk, higher NNE values were observed.

"Over the 10-year study period, accuracy in melanoma detection improved only in specialized clinics maybe because of a larger use of new such as dermatoscopy," the authors write.

Explore further: Melanoma screening by physicians associated with finding more cancers than patient self-detection

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Melanoma screening by physicians associated with finding more cancers than patient self-detection

July 18, 2011
Physician-based screening for melanoma is associated with higher rates of physician-detected melanoma and detection of thinner melanoma, according to a report published Online First today by Archives of Dermatology, one of ...

Slow-growing melanomas lose structure, vary color with time

June 1, 2012
(HealthDay) -- The diameter of most slow-growing melanomas (SGMs) changes very little over time, but the lesions can become more disorganized, less structured, and change or develop new colors, according to a study published ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.